Literature DB >> 24265028

Intriguing properties of the angucycline antibiotic auricin and complex regulation of its biosynthesis.

Jan Kormanec1, Renata Novakova, Erik Mingyar, Lubomira Feckova.   

Abstract

Streptomyces bacteria are major producers of bioactive natural products, including many antibiotics. We identified a gene cluster, aur1, in a large linear plasmid of Streptomyces aureofaciens CCM3239. The cluster is responsible for the production of a new angucycline polyketide antibiotic auricin. Several tailoring biosynthetic genes were scatted in rather distant aur1 flanking regions. Auricin was produced in a very narrow growth phase interval of several hours after entry into stationary phase, after which it was degraded to non-active metabolites because of its instability at the high pH values reached after the production stage. Strict transcriptional regulation of the auricin biosynthetic gene cluster has been demonstrated, including feed-forward and feedback control by auricin intermediates via several of the huge number of regulatory genes present in the aur1 cluster. The complex mechanism may ensure strict confinement of auricin production to a specific growth stage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24265028     DOI: 10.1007/s00253-013-5373-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

Review 1.  The regulatory cascades of antibiotic production in Streptomyces.

Authors:  Haiyang Xia; Xinqiao Zhan; Xu-Ming Mao; Yong-Quan Li
Journal:  World J Microbiol Biotechnol       Date:  2020-01-02       Impact factor: 3.312

2.  A Complex Signaling Cascade Governs Pristinamycin Biosynthesis in Streptomyces pristinaespiralis.

Authors:  Yvonne Mast; Jamil Guezguez; Franziska Handel; Eva Schinko
Journal:  Appl Environ Microbiol       Date:  2015-07-17       Impact factor: 4.792

3.  A stable vector for efficient production of heterologous proteins and secondary metabolites in streptomycetes.

Authors:  Renata Novakova; Dagmar Homerova; Dominika Csolleiova; Bronislava Rezuchova; Beatrica Sevcikova; Rachel Javorova; Lubomira Feckova; Jan Kormanec
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-29       Impact factor: 5.560

4.  Complete Genome Sequence of Streptomyces lavendulae subsp. lavendulae CCM 3239 (Formerly "Streptomyces aureofaciens CCM 3239"), a Producer of the Angucycline-Type Antibiotic Auricin.

Authors:  Tobias Busche; Renata Novakova; Arwa Al'Dilaimi; Dagmar Homerova; Lubomira Feckova; Bronislava Rezuchova; Erik Mingyar; Dominika Csolleiova; Carmen Bekeova; Anika Winkler; Beatrica Sevcikova; Jörn Kalinowski; Jan Kormanec; Christian Rückert
Journal:  Genome Announc       Date:  2018-03-01

5.  A Structural Analysis of the Angucycline-Like Antibiotic Auricin from Streptomyces lavendulae Subsp. Lavendulae CCM 3239 Revealed Its High Similarity to Griseusins.

Authors:  Maria Matulova; Lubomira Feckova; Renata Novakova; Erik Mingyar; Dominika Csolleiova; Martina Zduriencikova; Jan Sedlak; Vladimir Patoprsty; Vlasta Sasinkova; Iveta Uhliarikova; Beatrica Sevcikova; Bronislava Rezuchova; Dagmar Homerova; Jan Kormanec
Journal:  Antibiotics (Basel)       Date:  2019-07-25

6.  Activation and Identification of a Griseusin Cluster in Streptomyces sp. CA-256286 by Employing Transcriptional Regulators and Multi-Omics Methods.

Authors:  Charlotte Beck; Tetiana Gren; Francisco Javier Ortiz-López; Tue Sparholt Jørgensen; Daniel Carretero-Molina; Jesús Martín Serrano; José R Tormo; Daniel Oves-Costales; Eftychia E Kontou; Omkar S Mohite; Erik Mingyar; Evi Stegmann; Olga Genilloud; Tilmann Weber
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

7.  A New Family of Transcriptional Regulators Activating Biosynthetic Gene Clusters for Secondary Metabolites.

Authors:  Renata Novakova; Erik Mingyar; Lubomira Feckova; Dagmar Homerova; Dominika Csolleiova; Bronislava Rezuchova; Beatrica Sevcikova; Rachel Javorova; Jan Kormanec
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.